FDA Newswatch

Food and Drug News for January 28, 2012

THE COCA-COLA COMPANY: 3rd UPDATE : FDA Finds Fungicide In Brazil Orange Juice Shipments
--First test results of Brazilian juice since problem was reported four weeks ago --Six shipments from Canada also test positive --Coca-Cola and Pepsi say products safe to consume (Adds Brazilian exporters' reaction in third and fifth paragraphs and safety information in the fourth paragraph.) WASHINGTON -(Dow Jones)- The U.S. government reported small amounts of carbendazim in Brazilian and Canadian ...
4 Traders - 2012-01-27 14:54:59

Pfizer's Inlyta gets FDA approval to treat patients with advanced kidney cancer
The FDA approved Inlyta to treat patients with advanced kidney cancer, renal cell carcinoma, who have not responded to another drug for this type of cancer. Inlyta is a pill that patients take twice a day. It is marketed Pfizer. :theflyonthewall.com Check below for free stories on PFE the last two weeks. There are 22 items on the Fly with pertinent information. Sign up for a free trial to ...
Financial Content - 2012-01-27 12:50:30

UPDATE: FDA Approves BYDUREON, for Type 2 Diabetes
Benzinga Staff Writer Symbols: ALKS, AMLN Posted in: News, FDA Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved BYDUREON' (exenatide extended-release for injectable suspension) ' the first once-weekly treatment for type 2 diabetes. BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated ...
Benzinga.com - 2012-01-27 15:00:23

BREAKING: FDA (finally) stamps an approval on Amylin's Bydureon
After being rejected twice by regulatory officials, Amylin has finally won FDA approval to sell Bydureon, it's once weekly diabetes jab. The weekly diabetes injection is intended to replace standard twice-a-day injections, and the NHS has already issued its approval in the UK, with NICE officials stamping an OK on the price earlier this week. In the U.S. the focus will now shift from the regulatory ...
FierceBiotech - 2012-01-27 15:00:57

UCB's Keppra Gets FDA Nod
UCB (UCBJF) was in the news again recently after the US Food and Drug Administration (FDA) approved its lead product, Keppra (levetiracetam), for use as adjunctive therapy for the treatment of partial onset seizures in adults and children aged one month and older suffering from epilepsy. The approval is for the tablet and oral formulation of the drug. We note that while Keppra is already available ...
Zacks.com - 2012-01-27 15:10:29

FDA Accepts Pfizer'€™s NDA For Bosutinib
armaceutical news and updates - Sign up now! Email Print Pfizer Inc. announced today that the FDA has accepted its New Drug Application (NDA) for standard review of bosutinib as a treatment option for adult patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML). This submission was based on efficacy and safety data from Study 200, a single-arm study of ...
PharmaceuticalProcessing - 2012-01-27 15:33:05

Discovery of new vaccine approach for treatment of cancer
...Scientists in Trinity College Dublin Ireland have developed a new va...The first cancer vaccine Sipuleucel-T (Provenge) was licensed last yea...Professor Mills' group has developed a novel vaccine and immunotherape...The findings... Date:1/27/2012 Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by ...
Bio-Medicine - 2012-01-27 11:32:56

Diagnostic brain tumor test could revolutionize care of patients
...DALLAS Jan. 26 2012 Researchers at UT Southwestern Medical Center h...This new magnetic resonance spectroscopy (MRS) technique provides a de... To our knowledge this is the only direct metabolic consequence of a ...UT Southwestern researchers developed the test by modifying the settin... Date:1/27/2012 DALLAS Jan. 26, 2012 Researchers at UT Southwestern Medical Center have developed what they believe ...
Bio-Medicine - 2012-01-27 11:32:56

Internal Fixation Systems Gains 510(k) Approval
Contract Manufacturing, Implants, Industry News, Orthopedics FDA's 510(k) Approval is granted for Internal Fixation Systems' subtalar implants that preserve motion. Share | Font size Internal Fixation Systems has received 510(k) clearance from the FDA to market subtalar implants. These implants are used to preserve motion at the ankle joint and to treat both trauma conditions and arthritis. IFS CEO, ...
Today's Medical Developments - 2012-01-27 10:20:32

New Discovery Could Help Control Alzheimer's Disease
A recently discovered protein in the brain could play a key role in controlling Alzheimer's disease. Researchers at Temple University say the protein is very active in the brains of people who suffer from the memory loss disease. The hope is to one day develop a way to block the protein from reaching the brain. Central Alabama Weather 59 15 F | C Clear Humidity: 44% Fri 38 | 58 3 | 14 Sat 31 | ...
WAKA CBS 8 - 2012-01-27 14:53:56